Postby rp1954 » Thu Mar 02, 2023 1:32 pm
Realities
You're not ready at this moment to go to ADAPT ++++ which is what your wife's degree of load would more likely respond to.
Historically, it's hard to say what some of Lin's mCRC patients' biggest successes (complete responses) were really like in terms of huge metastatic load vs "merely" some chemo hardened multisite spread when starting on ADAPT alone.
(Xeloda vs) ADAPT vs ADAPT ++ vs ADAPT ++++ are going to have different yield curves.
Those of us here with some degree of daily chemo (ADAPT, UFT-LV) experience and +s built up to it experimently, mostly perioperatively with reduced or lower loads.
To me, ADAPT and ADAPT++ with a high load, are about trying stop spread and maybe slowing growth or dint some mets.
Salvage surgeries are the likely backup requirement for large CEA drop on ADAPT, complete and partial responses on chemo being % successes.
With my wife, one notable immunochemo action (2-3 cm liver objects on CT) is hard to separate between improved activity due to surgically reduced tumor burden, and improved immuno chemistry, I credit both.
Our limited experience base revolves around people heading into surgery, after surgery, or limited tumor burden.
Our ++ experience starts with my wife getting ahead before her first surgery, before chemo, with a huge necrosis and/or immune reaction, probably starting between day1 and day14 after dx. Then some months on chemo trials beyond the local dr's direct experience levels but spread over 15 months of research and preparation. Of course that compresses greatly with experience and good support.
I had hoped one high burden patient would make the switch from Folfoxiri after a substantial marker reduction but they were delayed, stayed too long on cyclic chemo, and burnt out on their CBC. Std oncology often drives to grade 3 or grade 4 side effects before backing off, kind of a scorched earth affair. Whereas home brewed between several dr's you need to fix it or back off between grade 1 or 2 side effects.
----
First, your std oncologist is not ready for ADAPT ++++ at all. And may never be.
If you could break the technical details down to him, he might be stunned silent, laugh, explode or some combination.
It took several years for our most interested oncologist to realize he needed to pay attention.
Kind of like Oumuamua, Inter Stellar object 1, moving fast and almost out of the solar system when finally noticed.
Some patients just get whatever scrip(s) possible for insurance and supply, then mostly work with other doctors.
In a crazy world, continuous supplies can be a big deal over several years if you don't prepare.
You need Drs who will support you for complications not even chemo based and help with large scrips, maybe whoever supports IVC.
An example would be ready to go on chemo with substantial COVID or vaccine after effects.
In western Canada, there were patients who had a clinic that combined Folfiri with IV vitamin C and K infusions. A clinic like that might be a partial support for an ADAPT patient (I don't know).
Second, you're not ready yet. I'd say you might hustle to ADAPT ++/+++ with some improved skills and drs right now.
You need your dr's, supplies, labs, your DIY efforts lined up and going to start at ADAPT+++ and then carefully transition into ADAPT++++, a high dose(!) chronomodulated version in a technical manner.
There is also some degree of transition between Folfox/Folfiri and xeloda because of excess leucovorin effects for several weeks.
If you continue your supplement and complementary program for Folfiri, I might call that Folfiri++, it's not continuous and not chronomodulated.
Folfiri++ should have notable advantages over Folfiri and some CEA drops but not quite the same benefits as ADAPT with +s.
Potentially the biggest benefit might be being able to chain incomplete, noncurative or locally curative cancer surgeries together in a curative manner.
watchful, active researcher and caregiver for stage IVb/c CC. surgeries 4/10 sigmoid etc & 5/11 para-aortic LN cluster; 8 yrs immuno-Chemo for mCRC; now no chemo
most of 2010 Life Extension recommendations and possibilities + more, some (much) higher, peaking ~2011-12, taper to almost nothing mid 2018, mostly IV C